Though it certainly doesn’t feel like it, Oracle (NASDAQ:ORCL) shares finished 2025 with respectable, market-beating gains ...

David Ellison may already be in a stronger position than his father was in 2003. The Paramount bid is all-cash, fully financed and carries a clear headline premium, even if WBD disputes elements of ...

Hospitals and health systems are entering a period of rapid acceleration in AI. Clinical leaders are reporting tangible gains, from automated note-taking to clearer visibility into patient histories, ...

Oracle's 2052 bonds are offering a rare 7% yield. Read about the risks and if they're right for income-focused investors.

In today’s fast-moving economy, companies that invest in AI-enabled tools and upskilling are better placed to grow, adapt and ...

Quick Read Oracle (ORCL) stock dropped over 40% from its September peak of $877B valuation. Oracle’s $300B OpenAI contract ...

There is no doubt what took centre stage in the theatre of business applications in 25: agentic AI, surpassing pre-2022 AI, ...

IT stocks generally offer moderate but consistent dividends. However, investors must remember that dividends are only one ...

Rural hospitals are overcoming fears of artificial intelligence and adopting tools that integrate with electronic health ...

Buffett has long advocated investing in reliable, low-risk index funds, such as the S&P 500, for most investors. If you’re ...

From early academic curiosity to enterprise-scale innovation, Rajesh G.’s journey reflects how strong foundations, continuous ...